Galectin Therapeutics Inc. Share Price
GALTGalectin Therapeutics Inc. Stock Performance
Open $2.77 | Prev. Close $2.84 | Circuit Range N/A |
Day Range $2.73 - $2.87 | Year Range $1.12 - $7.13 | Volume 12,971 |
Average Traded $2.81 |
Galectin Therapeutics Inc. Share Price Chart
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $2.77 | $2.81 | -0.71% |
05-Feb-26 | $2.92 | $2.83 | -4.39% |
04-Feb-26 | $3.04 | $2.96 | -9.48% |
03-Feb-26 | $3.07 | $3.27 | +8.46% |
02-Feb-26 | $2.90 | $3.02 | +6.54% |
30-Jan-26 | $2.83 | $2.83 | -3.41% |
29-Jan-26 | $3.02 | $2.93 | -5.02% |
FAQs on Galectin Therapeutics Inc. Share Price
Can I buy Galectin Therapeutics Inc. shares in India?
What is the share price of Galectin Therapeutics Inc.?
What is the 5 year returns of Galectin Therapeutics Inc.?
What are the high & low stock price of Galectin Therapeutics Inc. today?
What is the 52-week high and low of Galectin Therapeutics Inc. stock?